Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers.

[1]  E. Bosmans,et al.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.

[2]  E. Bosmans,et al.  Indicators of immune activation in major depression , 1996, Psychiatry Research.

[3]  M. Maes,et al.  The monocyte-T-lymphocyte hypothesis of major depression , 1995, Psychoneuroendocrinology.

[4]  B. Hu,et al.  Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[5]  D. J. Claliw.  The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia , 1995 .

[6]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  A. García,et al.  Lymphocyte subpopulations in patients with primary fibromyalgia. , 1994, The Journal of rheumatology.

[8]  H. Meltzer,et al.  Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response , 1994, Psychiatry Research.

[9]  B. Danneskiold-Samsøe,et al.  A blinded, controlled evaluation of anxiety and depressive symptoms in patients with fibromyalgia, as measured by standardized psychometric interview scales , 1994, Acta psychiatrica Scandinavica.

[10]  B. Leonard,et al.  Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. , 1994, Journal of affective disorders.

[11]  P. Blockx,et al.  Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic–pituitary–adrenal axis in depression , 1994, Psychological Medicine.

[12]  F. Wolfe,et al.  Depression is not more common in rheumatoid arthritis: a 10-year longitudinal study of 6,153 patients with rheumatic disease. , 1993, The Journal of rheumatology.

[13]  F. Eyskens,et al.  Urinary Excretion of Purine and Pyrimidine Metabolites in the Neonate , 1993, Pediatric Research.

[14]  Bridges Aj.  Fibromyalgia, antinuclear antibodies and clinical features of connective tissue disease. , 1993 .

[15]  M. Yunus,et al.  Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. , 1993, The Journal of rheumatology.

[16]  A. Gam,et al.  Bone mass and turnover in fibromyalgia. , 1993, The Journal of rheumatology.

[17]  P. Joyce,et al.  Elevated levels of acute phase plasma proteins in major depression , 1992, Biological Psychiatry.

[18]  G. Mellsop,et al.  Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia , 1992, Psychological Medicine.

[19]  R. Klein,et al.  Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome , 1992, Psychoneuroendocrinology.

[20]  M. Abou-Saleh,et al.  Pterin metabolism in depression: an extension of the amine hypothesis and possible marker of response to ECT , 1992, Psychological Medicine.

[21]  S. Markey,et al.  Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse , 1992, Neuroscience.

[22]  C. Thomsen,et al.  31P magnetic resonance spectroscopy of skeletal muscle in patients with fibromyalgia. , 1992, The Journal of rheumatology.

[23]  I. Caruso,et al.  Primary Fibromyalgia Syndrome and 5-Hydroxy-L-Tryptophan: A 90-Day Open Study , 1992, The Journal of international medical research.

[24]  P. Cosyns,et al.  Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. , 1992, Journal of affective disorders.

[25]  R. S. Smith.  The macrophage theory of depression. , 1991, Medical hypotheses.

[26]  Korff Kj.  Primary fibromyalgia syndrome , 1990 .

[27]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[28]  Russell Ij.  Neurohormonal aspects of fibromyalgia syndrome. , 1989 .

[29]  Mitler Mm,et al.  Fibromyalgia. 2. Management guidelines and research findings. , 1986 .

[30]  D. Goldenberg,et al.  Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. , 1985, The American journal of psychiatry.

[31]  J. Davidson,et al.  Urinary excretion of bioterin and neopterin in psychiatric disorders , 1984, Psychiatry Research.

[32]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[33]  D. Miller,et al.  Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. , 1997, Brain : a journal of neurology.

[34]  V. Arolt,et al.  Increased CD56+ natural killer cells and related cytokines in major depression. , 1996, Clinical immunology and immunopathology.

[35]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[36]  A. Bridges.  Autoantibodies in patients with silicone implants. , 1994, Seminars in arthritis and rheumatism.

[37]  Z. Traczyk,et al.  Comparison of Urinary Neopterin and Pseudouridine in Patients with Malignant Proliferative Diseases , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[38]  M. Yunus,et al.  Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. , 1992, The Journal of rheumatology.

[39]  I. Russell,et al.  Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. , 1992, The Journal of rheumatology.

[40]  M. Heyes,et al.  Increased L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid concentrations in cerebral cortex following systemic endotoxin administration. , 1991, Advances in experimental medicine and biology.

[41]  G. K. Smith,et al.  Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. , 1985, Annual review of biochemistry.

[42]  F. Valentine,et al.  Cell-mediated immunity. , 1971, Advances in internal medicine.